{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:09:29Z","timestamp":1793916569511,"version":"4.8.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24721-1","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:38:48Z","timestamp":1763635128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of risk factors and predictive modelling of biomarkers in subclinical hypothyroidism and implications for levothyroxine therapy in disease management"],"prefix":"10.1038","volume":"15","author":[{"given":"Hiya","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibakar","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhasish","family":"Pramanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhankar","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"6","key":"24721_CR1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.4158\/EP12280.GL","volume":"18","author":"JR Garber","year":"2012","unstructured":"Garber, J. R. et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American association of clinical endocrinologists and the American thyroid association. Endocr. Pract. 18(6), 988\u20131028. https:\/\/doi.org\/10.4158\/EP12280.GL (2012).","journal-title":"Endocr. Pract."},{"issue":"14\u201315","key":"24721_CR2","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.clinbiochem.2011.07.003","volume":"44","author":"RK Marwaha","year":"2011","unstructured":"Marwaha, R. K. et al. Dyslipidemia in subclinical hypothyroidism in an Indian population. Clin. Biochem. 44(14\u201315), 1214\u20131217. https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.07.003 (2011).","journal-title":"Clin. Biochem."},{"issue":"1","key":"24721_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/trp.trp_4_23","volume":"19","author":"R Rajput","year":"2022","unstructured":"Rajput, R. et al. Subclinical hypothyroidism in adults: consensus statement of Indian thyroid society. Thyroid Res. Pract. 19(1), 8\u201323. https:\/\/doi.org\/10.4103\/trp.trp_4_23 (2022).","journal-title":"Thyroid Res. Pract."},{"issue":"6","key":"24721_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s11886-004-0054-3","volume":"6","author":"EN Pearce","year":"2004","unstructured":"Pearce, E. N. Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr. Cardiol. Rep. 6(6), 451\u2013456. https:\/\/doi.org\/10.1007\/s11886-004-0054-3 (2004).","journal-title":"Curr. Cardiol. Rep."},{"issue":"12","key":"24721_CR5","doi-asserted-by":"publisher","first-page":"e005266","DOI":"10.1161\/CIRCHEARTFAILURE.118.005266","volume":"11","author":"L Kannan","year":"2018","unstructured":"Kannan, L. et al. Thyroid dysfunction in heart failure and cardiovascular outcomes. Circ. Heart Fail. 11(12), e005266. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.118.005266 (2018).","journal-title":"Circ. Heart Fail."},{"key":"24721_CR6","doi-asserted-by":"publisher","first-page":"614030","DOI":"10.3389\/fcell.2020.614030","volume":"8","author":"R De Luca","year":"2021","unstructured":"De Luca, R. et al. Thyroid hormones interaction with immune Response, inflammation and Non-thyroidal illness syndrome. Front. Cell. Dev. Biol. 8, 614030. https:\/\/doi.org\/10.3389\/fcell.2020.614030 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"24721_CR7","doi-asserted-by":"publisher","first-page":"1332383","DOI":"10.3389\/fendo.2023.1332383","volume":"14","author":"R Lai","year":"2024","unstructured":"Lai, R. et al. The causal relationship between 41 inflammatory cytokines and hypothyroidism: bidirectional two-sample Mendelian randomization study. Front. Endocrinol. (Lausanne). 14, 1332383. https:\/\/doi.org\/10.3389\/fendo.2023.1332383 (2024).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"24721_CR8","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1530\/EJE-21-1171","volume":"186","author":"C Wenzek","year":"2022","unstructured":"Wenzek, C. et al. The interplay of thyroid hormones and the immune system - where we stand and why we need to know about it. Eur. J. Endocrinol. 186(5), R65\u2013R77. https:\/\/doi.org\/10.1530\/EJE-21-1171 (2022).","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"24721_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello, C. A. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol. Rev. 281(1), 8\u201327. https:\/\/doi.org\/10.1111\/imr.12621 (2018).","journal-title":"Immunol. Rev."},{"issue":"4","key":"24721_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cytogfr.2011.10.001","volume":"22","author":"G Lopez-Castejon","year":"2011","unstructured":"Lopez-Castejon, G. & Brough, D. Understanding the mechanism of IL-1\u03b2 secretion. Cytokine Growth Factor. Rev. 22(4), 189\u2013195. https:\/\/doi.org\/10.1016\/j.cytogfr.2011.10.001 (2011).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"11","key":"24721_CR11","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41419-018-1121-9","volume":"9","author":"C Semino","year":"2018","unstructured":"Semino, C., Carta, S., Gattorno, M., Sitia, R. & Rubartelli, A. Progressive waves of IL-1\u03b2 release by primary human monocytes via sequential activation of vesicular and gasdermin D-mediated secretory pathways. Cell. Death Dis. 9(11), 1088. https:\/\/doi.org\/10.1038\/s41419-018-1121-9 (2018).","journal-title":"Cell. Death Dis."},{"key":"24721_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-020-0167-x","volume":"6","author":"D Zheng","year":"2020","unstructured":"Zheng, D., Liwinski, T. & Elinav, E. Inflammasome activation and regulation: toward a better Understanding of complex mechanisms. Cell. Discov. 6, 36. https:\/\/doi.org\/10.1038\/s41421-020-0167-x (2020).","journal-title":"Cell. Discov"},{"issue":"1","key":"24721_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s11658-023-00462-9","volume":"28","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. The NLRP3 inflammasome: contributions to inflammation-related diseases. Cell. Mol. Biol. Lett. 28(1), 51. https:\/\/doi.org\/10.1186\/s11658-023-00462-9 (2023).","journal-title":"Cell. Mol. Biol. Lett."},{"key":"24721_CR14","doi-asserted-by":"publisher","first-page":"483","DOI":"10.7326\/0003-4819-151-7-200910060-00009","volume":"151","author":"DI Buckley","year":"2009","unstructured":"Buckley, D. I., Fu, R., Freeman, M., Rogers, K. & Helfand, M. C-reactive protein as a risk Fator for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive services task forces. Ann. Intern. Med. 151, 483\u2013495 (2009).","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"24721_CR15","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","volume":"22","author":"DI Jang","year":"2021","unstructured":"Jang, D. I. et al. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int. J. Mol. Sci. 22(5), 2719. https:\/\/doi.org\/10.3390\/ijms22052719 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"24721_CR16","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1182\/blood.V91.1.258","volume":"91","author":"P Biswas","year":"1998","unstructured":"Biswas, P. et al. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 91(1), 258\u2013265 (1998).","journal-title":"Blood"},{"issue":"10","key":"24721_CR17","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka, T., Narazaki, M. & Kishimoto, T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect. Biol. 6(10), a016295. https:\/\/doi.org\/10.1101\/cshperspect.a016295 (2014).","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"24721_CR18","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3389\/fimmu.2019.01078","volume":"10","author":"H Harjunp\u00e4\u00e4","year":"2019","unstructured":"Harjunp\u00e4\u00e4, H., Llort Asens, M., Guenther, C. & Fagerholm, S. C. Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Front. Immunol. 10, 1078. https:\/\/doi.org\/10.3389\/fimmu.2019.01078 (2019).","journal-title":"Front. Immunol."},{"issue":"2","key":"24721_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0165-5728(94)90083-3","volume":"51","author":"P Shrikant","year":"1994","unstructured":"Shrikant, P., Chung, I. Y., Ballestas, M. E. & Benveniste, E. N. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-alpha, interleukin-1 beta, and interferon-gamma in astrocytes. J. Neuroimmunol. 51(2), 209\u2013220. https:\/\/doi.org\/10.1016\/0165-5728(94)90083-3 (1994).","journal-title":"J. Neuroimmunol."},{"key":"24721_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/eurheartj\/eht367","volume":"35","author":"S Kaptoge","year":"2014","unstructured":"Kaptoge, S. et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur. Heart J. 35, 587\u2013589 (2014).","journal-title":"Eur. Heart J."},{"issue":"4","key":"24721_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000356507","volume":"2","author":"SHS Pearce","year":"2013","unstructured":"Pearce, S. H. S. et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur. Thyroid J. 2(4), 215\u2013228. https:\/\/doi.org\/10.1159\/000356507 (2013).","journal-title":"Eur. Thyroid J."},{"key":"24721_CR22","volume-title":"DeGroot\u2019s Endocrinology","author":"JD Faix","year":"2023","unstructured":"Faix, J. D. Thyroid function testing (thyrotropin, triiodothyronine, and thyroxine). In: (ed Robertson, R. P.) DeGroot\u2019s Endocrinology 8th ed (Elsevier, 2023).","edition":"8"},{"issue":"2","key":"24721_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","volume":"14","author":"A Antonelli","year":"2015","unstructured":"Antonelli, A., Ferrari, S. M., Corrado, A., Di Domenicantonio, A. & Fallahi, P. Autoimmune thyroid disorders. Autoimmun. Rev. 14(2), 174\u2013180. https:\/\/doi.org\/10.1016\/j.autrev.2014.10.016 (2015).","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"24721_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.2019.9052","volume":"322","author":"B Biondi","year":"2019","unstructured":"Biondi, B., Cappola, A. R. & Cooper, D. S. Subclinical hypothyroidism: a review. JAMA 322(2), 153\u2013160. https:\/\/doi.org\/10.1001\/jama.2019.9052 (2019).","journal-title":"JAMA"},{"issue":"3","key":"24721_CR25","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1210\/jcem.87.3.8165","volume":"87","author":"S Andersen","year":"2002","unstructured":"Andersen, S., Pedersen, K. M., Bruun, N. H. & Laurberg, P. Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the Understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab. 87(3), 1068\u20131072. https:\/\/doi.org\/10.1210\/jcem.87.3.8165 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"24721_CR26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3109\/00365517609055286","volume":"36","author":"J Weeke","year":"1976","unstructured":"Weeke, J. & Laurberg, P. Diurnal variation of the serum Thyrotropin (TSH) level in normal subjects. Scand. J. Clin. Lab. Invest. 36(8), 783\u2013787. https:\/\/doi.org\/10.3109\/00365517609055286 (1976).","journal-title":"Scand. J. Clin. Lab. Invest."},{"issue":"1","key":"24721_CR27","doi-asserted-by":"publisher","first-page":"15861","DOI":"10.1038\/s41598-020-73009-z","volume":"10","author":"A Chatterjee","year":"2020","unstructured":"Chatterjee, A. et al. Insight into the distinctive paradigm of human cytomegalovirus associated intrahepatic and extrahepatic cholestasis in neonates. Sci. Rep. 10(1), 15861. https:\/\/doi.org\/10.1038\/s41598-020-73009-z (2020).","journal-title":"Sci. Rep."},{"key":"24721_CR28","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.1038\/s41598-022-11727-2","volume":"12","author":"A Chatterjee","year":"2022","unstructured":"Chatterjee, A. et al. A comparative analysis depicting the disease characteristics and phylogenetic signature of human cytomegalovirus infection in human immunodeficiency virus 1 seropositive patients with end-organ retinitis and gastro-enteric diseases. Sci. Rep. 12, 7617. https:\/\/doi.org\/10.1038\/s41598-022-11727-2 (2022).","journal-title":"Sci. Rep."},{"issue":"7","key":"24721_CR29","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00467-020-04523-5","volume":"35","author":"A Chatterjee","year":"2020","unstructured":"Chatterjee, A. et al. A cross-sectional study exploring disease characteristics and phylogenetic nature of human cytomegalovirus among infected neonates with congenital nephrotic syndrome. Pediatr. Nephrol. 35(7), 1257\u20131266. https:\/\/doi.org\/10.1007\/s00467-020-04523-5 (2020).","journal-title":"Pediatr. Nephrol."},{"issue":"3","key":"24721_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/00401706.1964.10490181","volume":"6","author":"OJ Dunn","year":"1964","unstructured":"Dunn, O. J. Multiple comparisons using rank sums. Technometrics 6(3), 241\u2013252 (1964).","journal-title":"Technometrics"},{"key":"24721_CR31","unstructured":"GraphPad & Software Inc. GraphPad Prism 10 Statistics Guide: Bonferroni and \u0160\u00edd\u00e1k methods and multiple comparisons following one-way ANOVA."},{"key":"24721_CR32","unstructured":"Van den Berg, R. G. SPSS Kolmogorov\u2013Smirnov Test for Normality: The Ultimate Guide. SPSS-Tutorials.com."},{"issue":"16","key":"24721_CR33","doi-asserted-by":"publisher","first-page":"e70028","DOI":"10.1111\/jcmm.70028","volume":"28","author":"SA Roghani","year":"2024","unstructured":"Roghani, S. A. et al. Interleukin-6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients. J. Cell. Mol. Med. 28(16), e70028. https:\/\/doi.org\/10.1111\/jcmm.70028 (2024).","journal-title":"J. Cell. Mol. Med."},{"key":"24721_CR34","doi-asserted-by":"crossref","unstructured":"Lopez-Castejon, G. & Brough, D. Understanding the mechanism of IL-1\u03b2 secretion. Cytokine Growth Factor Rev 22(4), 189\u2013195 (2011).","DOI":"10.1016\/j.cytogfr.2011.10.001"},{"key":"24721_CR35","doi-asserted-by":"crossref","unstructured":"Tschopp, J. Z& Schroder, K. NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat. Rev. Immunol.  10(3), 210\u2013215 (2010).","DOI":"10.1038\/nri2725"},{"key":"24721_CR36","doi-asserted-by":"publisher","first-page":"674841","DOI":"10.3389\/fendo.2021.674841","volume":"12","author":"LE Zijlstra","year":"2021","unstructured":"Zijlstra, L. E. et al. Levothyroxine treatment and cardiovascular outcomes in older people with subclinical hypothyroidism: pooled individual results of two randomised controlled trials. Front. Endocrinol. (Lausanne). 12, 674841. https:\/\/doi.org\/10.3389\/fendo.2021.674841 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"24721_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2006.11.026","volume":"195","author":"Y Kamari","year":"2007","unstructured":"Kamari, Y. et al. Differential role and tissue specificity of interleukin-1_ gene expression in atherogenesis and lipid metabolism. Atherosclerosis 195, 31\u201338 (2007).","journal-title":"Atherosclerosis"},{"issue":"1","key":"24721_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13044-024-00199-3","volume":"17","author":"BM Alomair","year":"2024","unstructured":"Alomair, B. M. et al. Increased thyroid stimulating hormone (TSH) as a possible risk factor for atherosclerosis in subclinical hypothyroidism. Thyroid Res. 17(1), 13. https:\/\/doi.org\/10.1186\/s13044-024-00199-3 (2024).","journal-title":"Thyroid Res."},{"issue":"8","key":"24721_CR39","doi-asserted-by":"publisher","first-page":"bqab077","DOI":"10.1210\/endocr\/bqab077","volume":"162","author":"C Yang","year":"2021","unstructured":"Yang, C. et al. TSH activates macrophage inflammation by G13- and G15-dependent pathways. Endocrinology 162(8), bqab077. https:\/\/doi.org\/10.1210\/endocr\/bqab077 (2021).","journal-title":"Endocrinology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24721-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T10:38:50Z","timestamp":1763635130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24721-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24721"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24721-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study received approval from the Institutional Ethics Committee (IEC), IPGME&R Kolkata Memo no: IPGME&R\/IEC\/2020\/007 Dated 27.01.2020 and informed consent was obtained from all subjects and all methods and procedures were carried out in accordance with Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"40946"}}